{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-015514","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2022-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.011960+00:00","generated_at":"2026-06-24T02:35:23.319991+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"RxSight Q2 revenue $11.4M (+132% YoY); raises FY22 guidance to $44-46M","bullets":["Revenue $11.4M (+132% YoY); sold 49 LDDs, installed base 294 (+126% YoY).","LAL procedure volumes 5,400 (+196% YoY).","Net loss $(16.7)M ($0.61/share); adjusted loss $(13.8)M ($0.50/share).","Raised FY22 revenue guidance to $44-46M (95-104% growth); gross margin guidance to 37-38%.","Cash and investments $128.6M; long-term debt $39.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-015514","json":"https://secwatch.observer/filing/0000950170-22-015514.json","markdown":"https://secwatch.observer/filing/0000950170-22-015514.md","text":"https://secwatch.observer/filing/0000950170-22-015514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/0000950170-22-015514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/rxst-20220808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T02:35:23.319991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}